Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transmission of HIV-1 drug-resistant variants: prevalence and effect on treatment outcome.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Feb 2010

Jakobsen Martin R, Tolstrup Martin, Søgaard Ole S, Jørgensen Louise B, Gorry Paul R, Laursen Alex, Ostergaard Lars

Abstract excerpt

BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) drug resistance is an important threat to the overall success of antiretroviral therapy (ART). Because of the limited sensitivity of commercial assays, transmitted drug resistance (TDR) may be underestimated; thus, the effect that TDR has on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Denmark
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Kaplan-Meier Estimate

Share to Proviruses

Share to Statistics, Nonparametric

Share to Viral Load

Source

Identifiers

PMID: 20085464
DOI: 10.1086/650001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20085464-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transmission of HIV-1 drug-resistant variants: prevalence and effect on treatment outcome.PMID 20085464Read ↗

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infectionSemantic proximity Read ↗

Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009.Semantic proximity Read ↗

Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy.Semantic proximity Read ↗

First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study.Semantic proximity Read ↗

Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy FailureSemantic proximity Read ↗

Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.Semantic proximity Read ↗

Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.Semantic proximity Read ↗

High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naïve chronically infected Brazilian blood donors.Semantic proximity Read ↗

Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.Semantic proximity Read ↗

Transmission of drug-resistant HIV-1 in Europe remains limited to single classes.Semantic proximity Read ↗

The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.Semantic proximity Read ↗

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.